Evidence map›Paper›PMID 19895577›Full record

ArticleThe FEBS journal2009

Side chain specificity of ADP-ribosylation by a sirtuin.

Kamau Fahie, Po Hu, Stephen Swatkoski, Robert J Cotter, Yingkai Zhang, Cynthia Wolberger

Open access · bronzeAbstract read
In one paragraph

Article in The FEBS journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Sirtuins of parasitic protozoa: in search of function(s).Molecular and biochemical parasitology · 2012
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Time-of-flights and traps: from the Histone Code to Mars.European journal of mass spectrometry (Chichester, England) · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Kamau FahieDepartment of Biophysics and Biophysical Chemistry, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Po Hu
Stephen Swatkoski
Robert J Cotter
Yingkai Zhang
Cynthia Wolberger
Johns Hopkins University · USNew York University · USHoward Hughes Medical Institute · USJohns Hopkins Medicine · US

Funding

TCP5: ACTIVE SITE LABELING REAGENT FOR ACETYLTRANSFERASESU54RR020839 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BOEKE, JEF D · 2004 to 2011
$27.4M
Computational Studies of Histone ModificationsR01GM079223 · NIGMS · NEW YORK UNIVERSITY · PI ZHANG, YINGKAI · 2007 to 2016
$2.4M
Howard Hughes Medical InstituteNCRR NIH HHS U54 RR020839NIGMS NIH HHS R01 GM079223NIGMS NIH HHS R01-GM-079223
6 · The paper itself

Abstract

Endogenous mono-ADP-ribosylation in eukaryotes is involved in regulating protein synthesis, signal transduction, cytoskeletal integrity, and cell proliferation, although few cellular ADP-ribosyltransferases have been identified. The sirtuins constitute a highly conserved family of protein deacetylases, and several family members have also been reported to perform protein ADP-ribosylation. We characterized the ADP-ribosylation reaction of the nuclear sirtuin homolog Trypanosoma brucei SIR2-related protein 1 (TbSIR2RP1) on both acetylated and unacetylated substrates. We demonstrated that an acetylated substrate is not required for ADP-ribosylation to occur, indicating that the reaction performed by TbSIR2RP1 is a genuine enzymatic reaction and not a side reaction of deacetylation. Biochemical and MS data showed that arginine is the major ADP-ribose acceptor for unacetylated substrates, whereas arginine does not appear to be the major ADP-ribose acceptor in reactions with acetylated histone H1.1. We performed combined ab initio quantum mechanical/molecular mechanical molecular dynamics simulations, which indicated that sirtuin ADP-ribosylation at arginine is energetically feasible, and involves a concerted mechanism with a highly dissociative transition state. In comparison with the corresponding nicotinamide cleavage in the deacetylation reaction, the simulations suggest that sirtuin ADP-ribosylation would be several orders slower but less sensitive to nicotinamide inhibition, which is consistent with experimental results. These results suggest that TbSIR2RP1 can perform ADP-ribosylation using two distinct mechanisms, depending on whether or not the substrate is acetylated.

Indexed as

AcetylationAdenosine Diphosphate RiboseADP Ribose TransferasesArginineModels, MolecularProtozoan ProteinsSirtuinsSubstrate SpecificityTrypanosoma brucei bruceiAdenosine Diphosphate RiboseADP Ribose TransferasesArginineProtozoan ProteinsSirtuins

Identifiers

PMID19895577
PMCPMC2805772
OpenAlexW1503162808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.